Harvey Partners’s Aspen Aerogels ASPN Stock Holding History

Harvey Partners’s Portfolio ASPN Stock Details ASPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-183,000	Closed	-$4.36M	–	44
2024 Q2	$4.36M	Sell	183,000 -94,500	-34%	-$2.22M	0.52%	39
2024 Q1	$4.88M	Sell	277,500 -25,000	-8%	-$368K	0.52%	38
2023 Q4	$4.77M	Hold	302,500	–	–	0.54%	37
2023 Q3	$2.6M	Buy	+302,500	New	+$2.15M	0.33%	40
2022 Q3	–	Sell	-55,231	Closed	-$546K	–	36
2022 Q2	$546K	Sell	55,231 -24,769	-31%	-$500K	0.12%	33
2022 Q1	$2.76M	Hold	80,000	–	–	0.68%	32
2021 Q4	$3.98M	Sell	80,000 -95,000	-54%	-$5.01M	1.62%	29
2021 Q3	$8.05M	Sell	175,000 -125,000	-42%	-$4.96M	6.02%	3
2021 Q2	$8.98M	Buy	300,000 +25,000	+9%	+$510K	6.22%	4
2021 Q1	$5.59M	Sell	275,000 -72,500	-21%	-$1.53M	3.86%	10
2020 Q4	$5.8M	Sell	347,500 -70,875	-17%	-$932K	4.03%	7
2020 Q3	$4.58M	Sell	418,375 -54,625	-12%	-$432K	5.95%	1
2020 Q2	$3.11M	Sell	473,000 -73,500	-13%	-$472K	3.75%	10
2020 Q1	$3.36M	Sell	546,500 -197,500	-27%	-$1.6M	3.04%	12
2019 Q4	$5.77M	Sell	744,000 -206,290	-22%	-$1.42M	3.28%	15
2019 Q3	$5.63M	Sell	950,290 -52,710	-5%	-$335K	4.07%	14
2019 Q2	$7.15M	Buy	1,003,000 +3,000	+0.3%	+$13.6K	9.86%	1
2019 Q1	$2.55M	Buy	1,000,000 +188,000	+23%	+$559K	4.22%	9
2018 Q4	$1.73M	Buy	812,000 +137,000	+20%	+$464K	4.35%	9
2018 Q3	$3.08M	Buy	675,000 +110,000	+19%	+$535K	4.29%	11
2018 Q2	$2.77M	Buy	565,000 +15,000	+3%	+$71.2K	3.61%	12
2018 Q1	$2.35M	Buy	550,000 +70,000	+15%	+$331K	3.47%	13
2017 Q4	$2.34M	Buy	480,000 +100,900	+27%	+$470K	2.97%	16
2017 Q3	$1.65M	Buy	379,100 +92,432	+32%	+$404K	1.89%	19
2017 Q2	$1.28M	Buy	286,668 +30,668	+12%	+$129K	1.46%	25
2017 Q1	$1.06M	Buy	256,000 +56,000	+28%	+$239K	1.28%	26
2016 Q4	$826K	Sell	200,000 -35,000	-15%	-$171K	0.87%	29
2016 Q3	$1.4M	Buy	235,000 +20,000	+9%	+$101K	1.68%	24
2016 Q2	$1.07M	Buy	+215,000	New	+$942K	1.07%	30

Other funds holding ASPN

KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return

GKFF

George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

ECA

Encompass Capital Advisors New York $3.34B AUM 167.64% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Harvey Partners's ASPN Position: Q3 2024 in Review

Harvey Partners sold out of Aspen Aerogels (ASPN) in Q3 2024, closing a stake of 183,000 shares — an estimated $4.36M sold.

Harvey Partners first reported a position in ASPN in Q2 2016 and held it in 29 quarters. The position peaked at $8.98M in Q2 2021. 243 funds tracked by Wall St. Rank hold ASPN as of Q3 2024.

Harvey Partners reported no remaining Aspen Aerogels position as of Q3 2024 after selling out during the quarter.
Harvey Partners sold 183,000 Aspen Aerogels shares in Q3 2024, an estimated $4.36M.
Harvey Partners first reported a position in Aspen Aerogels in Q2 2016 and held it in 29 quarters.
Harvey Partners's Aspen Aerogels position peaked at $8.98M in Q2 2021.
243 funds tracked by Wall St. Rank held Aspen Aerogels as of Q3 2024.

Based on Harvey Partners's 13F filing for Q3 2024, filed 14 Nov 2024.